UNSPSC 51422409: Deoxycorticosterone or desoxycorticosterone or desoxycortone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40GP35YQ49, chemically known as 21-hydroxypregn-4-ene-3,20-dione but generally known as deoxycorticosterone, which bears US NIH Compound Identifier 6166. SMILES: CC12CCC3C(C1CCC2C(=O)CO)CCC4=CC(=O)CCC34C.

UNSPSC 51422409 Deoxycorticosterone or desoxycorticosterone or desoxycortone is a Commodity code that carries a significant mismatch between its nominal pharmaceutical scope and actual recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, which are emergency response and harm-reduction products bearing no pharmacological relationship to deoxycorticosterone, a corticosteroid hormone. The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs, provide unit costs for each line item, and comply with drug-free workplace certification and E-Verify requirements. The contract runs two years with a one-year renewal option, carries a three-month probationary termination period, and is potentially funded through FEMA with associated federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent activity and lacks clear relevance to its stated pharmaceutical category. Only Seminole County, Florida appears in the recent opportunities block, with no geographic spread across multiple states or repeat issuers to characterize. The mismatch between the code's corticosteroid nominal scope and Naloxone procurement suggests either a tagging error in the source system or that this Commodity code does not reliably categorize actual state and local buying patterns. Firms pursuing opportunities under this code should verify category alignment before bid preparation, as the single available recent opportunity falls outside the code's stated pharmaceutical domain.